Free Trial

Neighbourly Pharmacy (NBLY) Stock Forecast & Price Target

Neighbourly Pharmacy logo

Neighbourly Pharmacy - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
3
Buy
0

Consensus Price Target

C$18.90
N/A
Get the Latest News and Ratings for NBLY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Neighbourly Pharmacy and its competitors.

Sign Up

NBLY Analyst Ratings Over Time

TypeCurrent Forecast
11/22/23 to 11/21/24
1 Month Ago
10/23/23 to 10/22/24
3 Months Ago
8/24/23 to 8/23/24
1 Year Ago
11/22/22 to 11/22/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
3 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetC$18.90C$18.90C$18.90C$23.07
Forecasted UpsideN/A1.61% Upside1.61% Upside30.42% Upside
Consensus Rating
Hold
Hold
Hold
Moderate Buy

NBLY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

NBLY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Neighbourly Pharmacy Stock vs. The Competition

TypeNeighbourly PharmacyMedical Companies
Consensus Rating Score
2.00
2.80
Consensus RatingHoldModerate Buy
News Sentiment Rating
Neutral News

See Recent NBLY News
Neutral News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
2/14/2024Desjardins
2 of 5 stars
 Lower TargetHoldC$20.00 ➝ C$18.50+0.71%
2/14/2024TD Securities
4 of 5 stars
 DowngradeOutperform ➝ Sector PerformC$28.00 ➝ C$18.50+0.71%
1/15/2024National Bankshares
1 of 5 stars
 Lower TargetSector Perform ➝ TenderC$20.50 ➝ C$18.50+1.54%
12/19/2023BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket PerformC$18.50 ➝ C$20.50+36.76%
12/19/2023Cormark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetC$20.50 ➝ C$18.50+23.42%
8/2/2023Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperformC$24.50 ➝ C$24.00+39.45%
7/13/2023Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperformC$34.00 ➝ C$28.00+77.89%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 10:29 AM ET.


NBLY Forecast - Frequently Asked Questions

According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for Neighbourly Pharmacy is C$18.90, with a high forecast of C$20.50 and a low forecast of C$18.50.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neighbourly Pharmacy in the last twelve months. There are currently 3 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" NBLY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NBLY, but not buy additional shares or sell existing shares.

According to analysts, Neighbourly Pharmacy's stock has a predicted upside of ∞ based on their 12-month stock forecasts.

Analysts like Neighbourly Pharmacy less than other "medical" companies. The consensus rating for Neighbourly Pharmacy is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how NBLY compares to other companies.


This page (TSE:NBLY) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners